lunes, 3 de noviembre de 2014

DELiA*s Rebounds As Reports Suggest Delisting May Be Imminent





Value Walk

11/03/14 – 02:17 PM EST

Billionaire stock picks dELiA*s, Inc. NASDAQ:
DLIA, AngloGold Ashanti Limited ADR NYSE:
AU and Enzon Pharmaceuticals Inc NASDAQ:
ENZN made big gains early in the day this Monday. Moving in the opposite direction are Corinthian Colleges Inc NASDAQ:
COCO, American Realty Capital Properties Inc NASDAQ:
ARCP and Laboratory Corp. of America Holdings NYSE:
LH.

Sign Up For Our Free Newsletter

dELiA*s

dELiA*s Climbs Despite Delisting Reports

dELiA*s, Inc.
(DLIA) climbed +36% early in the day, though today’s boost may not be enough to
save it from delisting – which
media outlets have suggested could be imminent. In the
Tiger Global portfolio since the fourth quarter of 2013, DLIA has declined -83.25% year-to-date.

AngloGold Ashanti Limited ADR
(AU) gained +21.16% after
reporting a sharp rise in profits for the third quarter. The gold mining company, a long-time
John Paulson investment, is still down -14.51% for the year.

Enzon Pharmaceuticals Inc
(ENZN) got a +12.09% boost early in the day, though it is still down -14.2% YTD. The biopharmaceutical company has been in
Carl Icahn’s investment portfolio across several quarters, and fellow billionaire
George Soros initiated a position in the firm in Q2.

American Realty Capital Properties Tumbles

Corinthian Colleges Inc
(COCO) dipped -9.78% this Monday. The for-profit educational company has faced a significant amount of criticism in recent months, and last week,
yet another lawsuit was filed against the firm. The new Q2 Soros buy has declined -90.89% YTD.

American Realty Capital Properties Inc
(ARCP) fell -8.34% after this morning’s
announcement that a deal with RCS Capital Corp. for the purchase of Cole Capital is off. ARCP, another Q2 acquisition for Soros, has lost -33.58% over the past month.

Laboratory Corp. of America Holdings
(LH) dipped -7.93% in the wake of
news that it will buy Covance Inc. in a deal worth 6.1 billion. Despite today’s drop, the clinical laboratory company, a
Ray Dalio holding, has gained +9.92% this year.

The post
dELiA*s Rebounds as Reports Suggest Delisting May Be Imminent appeared first on
ValueWalk.

-By iBillionaire

LikeTweet

No hay comentarios:

Publicar un comentario